Christopher Perry
Co-Applicant
Professor in the School of Kinesiology and Health Sciences at York University in Toronto, ON, Canada
Associate Director of the Muscle Health Research Centre at York University in Toronto, ON, Canada
NMD4C Involvement: Pillar 1: Preclinical Science
Research Interests: mitochondria, muscle, Duchenne, neuromuscular disease, muscle weakness, reactive oxygen species, oxidative stress, redox biology, metabolism
Academic web profileGoogle Scholar profile
LinkedIn profile
ResearchGate profile
ORCiD profile
Biography
Dr. Christopher Perry is a Professor in the School of Kinesiology and Health Science and Associate Director of the Muscle Health Research Centre at York University in Toronto, Ontario, Canada. His laboratory aims to understand how mitochondrial stress contributes to muscle weakness in a variety of disorders including Duchenne muscular dystrophy.
Ongoing work examines how certain muscles demonstrate dynamic resliency during cancer in an attempt to slow the progression of muscle weakness. Our team has also identified several compounds that partially restore muscle health in a mouse model of Duchenne muscular dystrophy by preserving mitochondrial metabolism. The lab also investigates how exercise improves muscle metabolism in humans and uses this information as the ‘mechanistic template’ for restoring healthy muscle function in diseases.
By working with clinical and industrial partners, the ultimate goal of the lab is to identify metabolic and redox stress-based mechanisms of muscle weakness and apply these findings towards the development of therapeutics that may help people improve muscle health, functional independence and quality of life.
Recent Publications
Ogilvie, LM, Delfinis, LJ, Coyle-Asbil, B, Vudatha, V, Alshamali, R, Garlisi, B et al.. Cardiac atrophy, dysfunction, and metabolic impairments: a cancer-induced cardiomyopathy phenotype. Am J Pathol. 2024. PMID:39032600
Gottlieb, D, Abushamat, LA, Nadeau, KJ, Regensteiner, JG, Reusch, JEB, Tommerdahl, KL et al.. Muscle mitochondrial function is impaired in adults with type 1 diabetes. J Diabetes Complications. 2024.38 (8)108798 PMID:38991492
Delfinis, LJ, Ogilvie, LM, Khajehzadehshoushtar, S, Gandhi, S, Garibotti, MC, Thuhan, AK et al.. Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia. Mol Metab. 2024.86 101976 PMID:38925248
Martin, G, Al-Sajee, D, Gingrich, M, Chattha, R, Akcan, M, Monaco, CMF et al.. Skeletal Muscle Mitochondrial Morphology Negatively Affected in Mice Lacking Xin. Biochem Cell Biol. 2024. PMID:38843556
Rebalka, IA, Noguchi, KS, Bulyovsky, KR, Badour, MI, Juracic, ES, Barrett, K et al.. Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls. PLoS One. 2024.19 (5)e0303448 PMID:38776307
Delfinis, LJ, Ogilvie, LM, Khajehzadehshoushtar, S, Gandhi, S, Garibotti, MC, Thuhan, AK et al.. Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexia. bioRxiv. 2024. PMID:38645227
Bellissimo, CA, Gandhi, S, Castellani, LN, Murugathasan, M, Delfinis, LJ, Thuhan, A et al.. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy. Am J Physiol Cell Physiol. 2024.326 (4)C1011-C1026 PMID:38145301
Miner, SES, McCarthy, MC, Ardern, CI, Perry, CGR, Toleva, O, Nield, LE et al.. The relationships between acetylcholine-induced chest pain, objective measures of coronary vascular function and symptom status. Front Cardiovasc Med. 2023.10 1217731 PMID:37719976
Bellissimo, CA, Castellani, LN, Finch, MS, Murugathasan, M, Gandhi, S, Sweeney, G et al.. Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688. Exp Physiol. 2023.108 (9)1108-1117 PMID:37415288
Garibotti, MC, Perry, CGR. Strength athletes and mitochondria: it's about 'time'. J Physiol. 2023.601 (14)2753-2754 PMID:37306149
See more on PubMed